4.7 Article

Glucagon-like Peptide 1 Receptor Activation Inhibits Microglial Pyroptosis via Promoting Mitophagy to Alleviate Depression-like Behaviors in Diabetic Mice

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Dysregulation of mitochondrial dynamics, mitophagy and apoptosis in major depressive disorder: Does inflammation play a role?

Giselli Scaini et al.

Summary: Recent studies have shown that mitochondrial dysfunction and dysregulated neuroinflammatory pathways play a role in major depressive disorder (MDD). This study found differences in markers of mitochondrial dynamics, mitophagy, autophagy, and apoptosis in MDD patients compared to healthy controls, with higher levels of specific proteins associated with mitochondrial dysfunction in MDD patients. Furthermore, inflammation and protein levels related to mitochondrial dynamics and mitophagy were found to influence the severity of depressive symptoms in MDD patients.

MOLECULAR PSYCHIATRY (2022)

Article Immunology

Didymin Suppresses Microglia Pyroptosis and Neuroinflammation Through the Asc/Caspase-1/GSDMD Pathway Following Experimental Intracerebral Hemorrhage

Lingui Gu et al.

Summary: Didymin treatment significantly improved neurobehavioral performance, reduced BBB disruption and brain water content, and mitigated microglial activation and neutrophil infiltration in the peri-hematoma tissue after ICH. The upregulation of Rkip expression by Didymin may play a key role in alleviating microglial pyroptosis and neuroinflammation through the Asc/Caspase-1/GSDMD pathway.

FRONTIERS IN IMMUNOLOGY (2022)

Review Pharmacology & Pharmacy

The role of glia in the physiology and pharmacology of glucagon-like peptide-1: implications for obesity, diabetes, neurodegeneration and glaucoma

Qi N. Cui et al.

Summary: The medical applications of GLP-1R agonists are expanding, with a focus on understanding the impact of GLP-1R signaling on energy balance, glycemic control, neuroinflammation, and oxidative stress in glial cells. The expression of GLP-1Rs in subsets of glial cells and infiltrating macrophages is now supported by evidence, leading to discussions on the effectiveness of GLP-1R agonists for treating metabolic and neurodegenerative diseases, enhancing cognition, and combating substance abuse.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Endocrinology & Metabolism

Activation of GIPR Exerts Analgesic and Anxiolytic-Like Effects in the Anterior Cingulate Cortex of Mice

Xin-shang Wang et al.

Summary: Chronic pain, often accompanied by anxiety disorders, is difficult to treat due to the exacerbating relationship between the two conditions. GIP, previously studied in neurodegenerative diseases, was found to have analgesic and anxiolytic effects in the treatment of chronic inflammatory pain and pain-related anxiety, possibly through attenuation of neuroinflammation and inhibition of excitatory transmission in the ACC. GIPR activation may be a promising target for future therapies.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Pharmacology & Pharmacy

The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists

Giulia Bendotti et al.

Summary: GLP-1RA has the ability to lower plasma glucose, induce weight loss, and possess anti-inflammatory properties, potentially modulating the immune system. This review examines the molecular mechanisms of GLP-1RA and explores their potential benefits in reducing inflammatory responses.

PHARMACOLOGICAL RESEARCH (2022)

Article Medicine, General & Internal

Variations in comorbidity burden in people with type 2 diabetes over disease duration: A population-based analysis of real world evidence

Jonathan Pearson-Stuttard et al.

Summary: Multimorbidity is common among people with T2DM, with the comorbidity profiles varying substantially. Two out of the top five comorbidities at diagnosis are traditional T2DM conditions, while the other three are not. The prevalence of each comorbidity increases over time, and patients with five or more comorbidities at diagnosis have a higher prevalence of each of the 35 comorbidities. People with obesity at diagnosis have significantly different comorbidity profiles, with the five commonest comorbidities being 50% more common in this group.

ECLINICALMEDICINE (2022)

Review Medicine, Research & Experimental

GLP-1 mimetics and cognition

Habib Yaribeygi et al.

Summary: GLP-1 receptor agonists not only improve glycemic control, but also have potential benefits in improving cognitive performance through multiple molecular mechanisms, which could be particularly beneficial for diabetic patients with cognitive impairments.

LIFE SCIENCES (2021)

Article Pharmacology & Pharmacy

Molecular mechanisms of mitophagy and its roles in neurodegenerative diseases

Xinnan Li et al.

Summary: Neurodegenerative diseases are common and incurable disorders in the elderly, with impaired mitophagy playing a significant role in their progression. Therapeutic strategies targeting mitophagy show promise in recent studies.

PHARMACOLOGICAL RESEARCH (2021)

Review Clinical Neurology

Depression, dementia and immune dysregulation

Shawn Hayley et al.

Summary: Major depression may be a precursor to cognitive decline and dementia, with chronic stress and inflammation compromising brain function and leading to depression and mild cognitive impairment. Treating inflammatory changes in depression can reverse the condition, and anti-inflammatory and antidepressant treatments may reduce or prevent dementia in individuals with depression. Chronic stress and inflammation may increase brain permeability and cytokine production, eventually manifesting as depression, cognitive impairment, and potentially dementia.

BRAIN (2021)

Article Immunology

Isoliquiritin ameliorates depression by suppressing NLRP3-mediated pyroptosis via miRNA-27a/SYK/NF-κB axis

Yuanjie Li et al.

Summary: The results showed that miRNA-27a expression was reduced in the serum of depressed patients and in animal models of depression. Isoliquiritin demonstrated significant antidepressant effects by decreasing NLRP3-mediated pyroptosis through the miRNA-27a/SYK/NF-kappa B axis.

JOURNAL OF NEUROINFLAMMATION (2021)

Article Biochemistry & Molecular Biology

Glucagon-like peptide-1 receptor activation maintains extracellular matrix integrity by inhibiting the activity of mitogen-activated protein kinases and activator protein-1

Yizhong Peng et al.

Summary: Exenatide has shown potential in regulating ECM synthesis balance and promoting disc reconstruction by inhibiting MAPK activation and downstream AP-1 activity, providing a new therapeutic rationale for treating intervertebral disc degeneration.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Review Immunology

The semantics of microglia activation: neuroinflammation, homeostasis, and stress

Samuel C. Woodburn et al.

Summary: Microglia are increasingly recognized as critical regulators of neuronal function and behavior in neuroscience. Research has shifted focus from their classical immune functions in pathological contexts to neuro-immune interactions in the absence of disease, injury, or infection. Standard methods to study and define microglial phenotype and function are being developed to facilitate the development of microglia-directed therapeutics in psychiatric and neurological diseases.

JOURNAL OF NEUROINFLAMMATION (2021)

Review Endocrinology & Metabolism

Depression in type 2 diabetes: A systematic review and meta-analysis of blood inflammatory markers

Michelle M. Nguyen et al.

Summary: This study found that individuals with type 2 diabetes and comorbid depression had higher levels of C-reactive protein and interleukin-6 in their blood, while lower levels of brain derived neurotrophic factor compared to those without depression.

PSYCHONEUROENDOCRINOLOGY (2021)

Review Pharmacology & Pharmacy

Role of mitophagy in mitochondrial quality control: Mechanisms and potential implications for neurodegenerative diseases

Xiao-Le Wang et al.

Summary: Neurodegenerative diseases result in the gradual loss of neurons, severely affecting the motor and cognitive abilities of patients. Mitochondrial dysfunction is a key factor in the pathology of these diseases, and mitophagy is crucial for maintaining neuronal health by clearing dysfunctional mitochondria.

PHARMACOLOGICAL RESEARCH (2021)

Review Nutrition & Dietetics

Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer's Disease

Dona Pamoda W. Jayatunga et al.

Summary: This study discusses the deficits of mitophagy in AD and examines potential molecular mechanisms of mitophagy activation, focusing on the role of urolithin A. Urolithin A, derived from ellagitannins, is known for its various health benefits including antioxidant, anti-inflammatory, anti-atherogenic, anti-A beta, and pro-mitophagy properties, but the specific mechanisms underlying its effects on mitophagy are not well understood.

NUTRIENTS (2021)

Article Biochemistry & Molecular Biology

Pretreatment with kaempferol attenuates microglia-mediate neuroinflammation by inhibiting MAPKs?NF??B signaling pathway and pyroptosis after secondary spinal cord injury

Zhongyuan Liu et al.

Summary: The study showed that kaempferol improved hindlimb motor function recovery and reduced spinal cord tissue damage in SCI rats. It suppressed microglia activation and oxidative stress, down-regulating ROS dependent MAPKs-NF-?B and pyroptosis signaling pathways to attenuate oxidative stress and inflammation.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Review Medicine, General & Internal

SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications

Emily Brown et al.

Summary: SGLT2 inhibitors and GLP-1 receptor agonists are effective in lowering glucose, weight loss, and blood pressure reduction, offering additional protection for cardiovascular disease in patients with type 2 diabetes. They are considered second-line therapies for diabetes, with prioritized consideration based on individual patient characteristics.

LANCET (2021)

Review Pharmacology & Pharmacy

The interaction between autophagy and neuroinflammation in major depressive disorder: From pathophysiology to therapeutic implications

Mimi Tang et al.

Summary: Neuroinflammation has been identified as an important mechanism of major depressive disorder, with the NLRP3 inflammasome playing a critical role in its pathogenesis. The autophagy signaling pathway is essential for regulating NLRP3 inflammasome activity, preventing excessive activation and release of inflammatory cytokines.

PHARMACOLOGICAL RESEARCH (2021)

Article Biochemistry & Molecular Biology

Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy

Xiaojuan Han et al.

Summary: This study demonstrated that Quercetin inhibits NLRP3 inflammasome activation in microglia by promoting mitophagy, thus preventing neuronal injury and providing a potential novel therapeutic strategy for neuroinflammation-related diseases.

REDOX BIOLOGY (2021)

Review Biochemistry & Molecular Biology

Mitophagy and Neuroprotection

Guofeng Lou et al.

TRENDS IN MOLECULAR MEDICINE (2020)

Review Clinical Neurology

Measures of depression and risk of type 2 diabetes: A systematic review and meta-analysis

Eva A. Graham et al.

JOURNAL OF AFFECTIVE DISORDERS (2020)

Article Materials Science, Biomaterials

Regulation of Autophagy Orchestrates Pyroptotic Cell Death in Molybdenum Disulfide Quantum Dot-Induced Microglial Toxicity

Peiyan Yang et al.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2020)

Review Psychiatry

Depressive symptoms and disorders in type 2 diabetes mellitus

Nirmalya Mukherjee et al.

CURRENT OPINION IN PSYCHIATRY (2019)

Review Medicine, Research & Experimental

Pathophysiological mechanisms involved in the relationship between diabetes and major depressive disorder

Gislaine Z. Reus et al.

LIFE SCIENCES (2017)

Article Pharmacology & Pharmacy

Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in Major depressive disorder

Elisabet Alcocer-Gomez et al.

PHARMACOLOGICAL RESEARCH (2017)

Review Cell Biology

Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control

Young-Sun Lee et al.

MEDIATORS OF INFLAMMATION (2016)

Article Biochemistry & Molecular Biology

Effect of Liraglutide on Corneal Kindling Epilepsy Induced Depression and Cognitive Impairment in Mice

Prashant Koshal et al.

NEUROCHEMICAL RESEARCH (2016)

Article Endocrinology & Metabolism

GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality

Rozita H. Anderberg et al.

PSYCHONEUROENDOCRINOLOGY (2016)

Review Immunology

The role of inflammation in depression: from evolutionary imperative to modern treatment target

Andrew H. Miller et al.

NATURE REVIEWS IMMUNOLOGY (2016)

Review Psychology

Adult Neurogenesis: Beyond Learning and Memory

Heather A. Cameron et al.

ANNUAL REVIEW OF PSYCHOLOGY, VOL 66 (2015)

Article Neurosciences

The Anterior Cingulate Cortex Is a Critical Hub for Pain-Induced Depression

Florent Barthas et al.

BIOLOGICAL PSYCHIATRY (2015)

Review Pharmacology & Pharmacy

Depression in Type 2 Diabetes Mellitus: Prevalence, Impact, and Treatment

Katherine Semenkovich et al.

DRUGS (2015)

Article Endocrinology & Metabolism

Depression and diabetes 2 The link between depression and diabetes: the search for shared mechanisms

Calum D. Moulton et al.

LANCET DIABETES & ENDOCRINOLOGY (2015)

Review Biochemistry & Molecular Biology

The pathways of mitophagy for quality control and clearance of mitochondria

G. Ashrafi et al.

CELL DEATH AND DIFFERENTIATION (2013)

Article Biochemistry & Molecular Biology

Chronic Variable Stress Alters Inflammatory and Cholinergic Parameters in Hippocampus of Rats

Barbara Tagliari et al.

NEUROCHEMICAL RESEARCH (2011)

Article Endocrinology & Metabolism

The prevalence of comorbid depression in adults with diabetes - A meta-analysis

RJ Anderson et al.

DIABETES CARE (2001)